 | • レポートコード：C-PMR-JN054 • 出版社/出版日：Persistence Market Research / 2018年10月 • レポート形態：英文、PDF、178ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：ライフサイエンス・トランスフォーメーションヘルス |
| Individual（１名、印刷不可） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（５名） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
This report examines the ‘Global Sarcopenia Treatment Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global sarcopenia treatment market.
The Sarcopenia Treatment Market is Segmented Based on:
Treatment Type
Distribution Channel
Regions
This report covers the global sarcopenia treatment market performance in terms of revenue contribution from various segments. The report begins with an overview and definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the global sarcopenia treatment market along with detailed opportunity analysis of the market. This is then followed by the key drivers, restraints and trends of the global sarcopenia treatment market.
The global sarcopenia treatment market is segmented based on treatment type, distribution channel and regions. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin B12 supplement, and vitamin D & calcium supplement. Based on distribution channels, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and hypermarket & supermarket. Geographically, the global sarcopenia treatment market is segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico and Rest of Latin America), Europe (Germany, France, the U.K., Italy, Spain, Russia and Rest of Europe), Asia Pacific (India, Australia, Japan, China and Rest of Asia Pacific), and Middle-East and Africa (GCC Countries, South Africa and Rest of MEA).
A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The forecast of the sarcopenia treatment market by country, treatment type, and distribution channel is represented in a tabular form for each region. This section will help to understand the present scenario and opportunities of the sarcopenia treatment market in major countries by each segment.
In the next section of the report, the ‘Competitive Landscape’ is included to provide the report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment. The detailed profiles of players operating in the sarcopenia treatment market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.
The next section of the report highlights the market outlook for 2018–2026 and sets the forecast within the context of the sarcopenia treatment market by region. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.
The above sections – by treatment type and distribution channel – evaluate the historic market analysis and growth prospects of the sarcopenia treatment market for the period 2018–2026. We have considered 2017 as the base year and provided data for the forecast period.
The final section of the report represents the global scenario of the sarcopenia treatment market along with y-o-y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall growth of the sarcopenia treatment market and the opportunity analysis for every year over the forecast period.
To arrive at the market size, bottom-up approach is used to validate the total market size obtained for the sarcopenia treatment market. The forecast presented in the report provides total revenue of the sarcopenia treatment market over 2018–2026. Triangulation methodology is used for market estimation that is primarily based on experimental techniques, such as patient-level data to obtain precise market estimations for sarcopenia treatment market and insights on specific country/regions. The country-specific data is again analyzed to derive data at a regional level and then at the global level. This methodology ensures high quality and accuracy of information.
The factors considered while developing the estimates of the sarcopenia treatment market prevalence of sarcopenia, available treatment options for sarcopenia, adoption of supplements for sarcopenia treatment, and prescription pattern for different supplements. The average selling price (US$) is derived by using weighted average pricing methodology.
The market value has also analyzed by considering the revenue from the key players operating in a segment. The key players are segmented at the tier level with respect to their revenue, product portfolio and geographical presence. This process involves analysis of various annual reports of companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.
Revenue growth of the key market players is analyzed over the historical period and market share of key players has been made in order to validate and align the resultant market numbers. The market structure is closely studied and analyzed at the regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.
While forecasting the size of the sarcopenia treatment market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, launch of new dietary and nutritional supplement brands and products, average consumption of different supplement among elderly across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global sarcopenia treatment market.
レポート目次1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Sarcopenia Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Trends
5. Key Inclusions
5.1. Sarcopenia Treatment Market Pipeline Assessment
5.2. Regulatory Guideline For Dietary Supplements
6. North America Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
6.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
6.4.1. Protein Supplement
6.4.2. Vitamin B12 Supplement
6.4.3. Vitamin D & Calcium Supplement
6.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
6.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies
6.6.3. Online Pharmacies
6.6.4. Hypermarket & Supermarket
6.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
6.8. Market Attractiveness Analysis
6.8.1. By Country
6.8.2. By Treatment Type
6.8.3. By Distribution Channel
7. Latin America Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
7.4.1. Protein Supplement
7.4.2. Vitamin B12 Supplement
7.4.3. Vitamin D & Calcium Supplement
7.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Online Pharmacies
7.6.4. Hypermarket & Supermarket
7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Treatment Type
7.8.3. By Distribution Channel
8. Europe Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
8.4.1. Protein Supplement
8.4.2. Vitamin B12 Supplement
8.4.3. Vitamin D & Calcium Supplement
8.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. Online Pharmacies
8.6.4. Hypermarket & Supermarket
8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Treatment Type
8.8.3. By Distribution Channel
9. Asia Pacific Excluding China Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
9.2.1. Japan
9.2.2. India
9.2.3. China
9.2.4. Australia and New Zealand
9.2.5. Rest of Asia Pacific
9.3. Market Size (US$ Mn) By Country, 2018–2026
9.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
9.4.1. Protein Supplement
9.4.2. Vitamin B12 Supplement
9.4.3. Vitamin D & Calcium Supplement
9.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
9.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. Online Pharmacies
9.6.4. Hypermarket & Supermarket
9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Treatment Type
9.8.3. By Distribution Channel
10. Middle East & Africa Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
10.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
10.4. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
10.4.1. Protein Supplement
10.4.2. Vitamin B12 Supplement
10.4.3. Vitamin D & Calcium Supplement
10.5. Market Size (US$ Mn) By Treatment Type, 2018–2026
10.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. Online Pharmacies
10.6.4. Hypermarket & Supermarket
10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.8. Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Treatment Type
10.8.3. By Distribution Channel
11. Forecast Assumptions
12. Driver Restraint Impact Analysis
13. Competition Analysis
13.1. Competition Dashboard
13.2. Company Deep Dive (Overview, Product Portfolio, Footprint, Strategy)
13.2.1. Abbott Laborites
13.2.2. Pfizer Inc.
13.2.3. Novartis AG
13.2.4. GlaxoSmithKline Plc.
13.2.5. Nestlé S.A.
13.2.6. Bayer AG
13.2.7. Sanofi S.A.
13.2.8. Amway
13.2.9. Cadila Healthcare Ltd.
13.2.10. Eli Lilly and Company
14. Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
14.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia Pacific
14.3.5. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Treatment Type
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2017
15.2.1. Protein Supplement
15.2.2. Vitamin B12 Supplement
15.2.3. Vitamin D & Calcium Supplement
15.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
15.4. Market Attractiveness Analysis By Treatment Type
16. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
16.2.1. Hospital Pharmacies
16.2.2. Retail Pharmacies
16.2.3. Online Pharmacies
16.2.4. Hypermarket & Supermarket
16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
16.4. Market Attractiveness Analysis By Distribution Channel
17. Global Sarcopenia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
17.1. Market Value Share Analysis By All Segment
17.2. Y-o-Y Growth Analysis By All Segment
17.3. Absolute $ Opportunity
18. Assumptions and Acronyms
19. Research Methodology
List of TableTable 01: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 02: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 03: North America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 04: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 05: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 06: Latin America Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 07: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 09: Europe Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 10: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 11: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 12: Asia Pacific Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 13: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 15: MEA Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 16: Global Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 17: Global Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 18: Global Sarcopenia Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel